Vor Biopharma (VOR) Accounts Payables (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Accounts Payables data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Accounts Payables fell 72.05% year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 72.05% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, up 240.66% from the prior year.
• Accounts Payables for Q1 2026 stood at $1.0 million, down from $5.1 million in the prior quarter.
• Over the last five years, Accounts Payables for VOR reached as high as $5.1 million in Q4 2025 and fell as low as $669000.0 in Q2 2025.
• Historically, Accounts Payables has averaged $1.8 million across 5 years, with a median of $1.3 million in 2024.
• Across the five-year window, Accounts Payables soared 240.66% in 2025 and slumped 72.05% in 2026, its largest moves.
• Year by year, Accounts Payables stood at $1.8 million in 2022, then sank by 54.01% to $815000.0 in 2023, then soared by 84.66% to $1.5 million in 2024, then surged by 240.66% to $5.1 million in 2025, then slumped by 79.66% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $1.0 million in Q1 2026, $5.1 million in Q4 2025, and $885000.0 in Q3 2025.